Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/26/1998DE19638534A1 Use of tocopheryl ferulate as skin bleaching agent
03/26/1998DE19638240A1 Oral composition for loosening and evacuating gallstones
03/26/1998CA2267348A1 Inositol polyphosphate derivatives and methods of using same
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2267290A1 Acid-functionalized saccharides as polyvalent anti-infectives
03/26/1998CA2267258A1 2-carbonylthiazole derivatives and use of the same
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266681A1 Use of benzopyranols to treat neurological disorders
03/26/1998CA2266656A1 Compositions and methods for treating intracellular diseases
03/26/1998CA2266505A1 Intermediates of duocarmycin sa and its derivatives and methods for producing the same
03/26/1998CA2266496A1 Pharmaceutical compositions and methods
03/26/1998CA2266447A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
03/26/1998CA2266425A1 Human b-cell translocation genes-2 and 3
03/26/1998CA2266404A1 Phospholipid drug derivatives
03/26/1998CA2266321A1 Substituted heterocycles as anti-tumor agents
03/26/1998CA2266070A1 Method of treating urinary incontinence
03/26/1998CA2265943A1 Phenoxathiin derivatives as inhibitors of monoamine oxidase
03/26/1998CA2265896A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998CA2265894A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications
03/26/1998CA2265827A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2238043A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998CA2237620A1 Platelet function increment agent and therapeutic method for thrombocytopathy
03/26/1998CA2236309A1 Use of inhibitors of retinoic acid activity for wound healing
03/26/1998CA2215856A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods
03/26/1998CA2214935A1 Benzofluorene compounds, intermediates, compositions, and methods
03/26/1998CA2214931A1 Tetrahydrobenzo-a-fluorene compounds and method of use
03/26/1998CA2214929A1 Naphthofluorene compounds, intermediates, compositions and methods
03/26/1998CA2214196A1 Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
03/26/1998CA2214176A1 Dihydrobenzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
03/25/1998EP0831098A2 Intermediates and process for preparing olanzapine
03/25/1998EP0831097A2 Olanzapine dihydrate D
03/25/1998EP0831090A1 N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them
03/25/1998EP0831089A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/25/1998EP0830864A1 Combination therapy for treatment of psychoses
03/25/1998EP0830863A1 Drugs for increasing gastrointestinal blood supply
03/25/1998EP0830862A1 Anti-hiv drugs
03/25/1998EP0830861A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
03/25/1998EP0830860A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of AIDS
03/25/1998EP0830858A1 Formulation comprising coated olanzapine particles
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830390A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
03/25/1998EP0830371A1 IMIDAZO 1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
03/25/1998EP0830369A1 Novel nor-pregnanes for inducing hypothalamic effects
03/25/1998EP0830367A1 High-affinity nucleic acid ligands of cytokines
03/25/1998EP0830360A1 Cytotoxic macrolides
03/25/1998EP0830357A1 Radiosensitizing diamines and their pharmaceutical preparations
03/25/1998EP0830352A1 Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
03/25/1998EP0830350A1 Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-3-yl)-acetamides
03/25/1998EP0830348A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
03/25/1998EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
03/25/1998EP0830346A1 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
03/25/1998EP0830345A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
03/25/1998EP0830344A1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
03/25/1998EP0830343A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
03/25/1998EP0830145A1 Formulations for lipophilic compounds
03/25/1998EP0830140A1 A pluripotent vaccine against enveloped viruses
03/25/1998EP0830139A1 Modified myelin protein molecules
03/25/1998EP0830136A1 New cryptophycins from synthesis
03/25/1998EP0830135A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
03/25/1998EP0830134A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders
03/25/1998EP0830132A1 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
03/25/1998EP0830131A1 New pharmacological use of aii-receptor antagonists
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0830129A1 Solid compositions containing polyethyleneoxide and a non-amorphous active principle
03/25/1998EP0802791A4 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
03/25/1998EP0801646A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
03/25/1998EP0799204A4 1,3,3-(trisubstituted)cyclohexane monomers and related compounds
03/25/1998EP0799186A4 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
03/25/1998EP0799185A4 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
03/25/1998EP0799184A4 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
03/25/1998EP0799182A4 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
03/25/1998EP0799181A4 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
03/25/1998EP0799036A4 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
03/25/1998EP0799031A4 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
03/25/1998EP0796097A4 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
03/25/1998EP0706556B1 Cleaning and disinfecting agent
03/25/1998EP0628040B1 Indole derivatives as steroid 5 alpha-reductase inhibitors
03/25/1998CN1177378A Stabilized external guide sequences
03/25/1998CN1177357A Bismuth compound
03/25/1998CN1177356A Bicyclic benzazepine derivatives as vasopressin antagonists
03/25/1998CN1177352A Prokinetic oxadiazoles
03/25/1998CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof
03/25/1998CN1177349A Certain 4 -aminomethyl -2 -substituted imidazole derivatives and 2 -aminomethyl -4 -substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
03/25/1998CN1177343A Cell adhesion inhibitors
03/25/1998CN1177301A Germanium yeast human diet nutritional supplement
03/25/1998CN1177300A Enrofloxacine injection or infusion solutions
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1177298A Remedy for pancreatitis
03/25/1998CN1177297A Medicament interded to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfuctions emesa and transport sickness
03/25/1998CN1177296A TNF-alpha injibition
03/25/1998CN1177295A Method of inhibiting growth hormone effects
03/25/1998CN1177294A Water based topical cream contg. nitroglycerin, prepn. method therefor and use thereof
03/25/1998CN1177292A Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
03/25/1998CN1176965A Novel pyrimido £1, 2 -alpha| indoles
03/25/1998CN1176964A New benzimidazole derivatives with antihistaminic activity
03/25/1998CN1176787A Method for producing bait with anti prawn disease function
03/25/1998CN1176786A (5-androstene -17 -one -3 beta hydroxyl) diacid ester, and it pharmaceutical use
03/25/1998CN1176784A Method for preparing masticatory tablet of acetaminophen, and the product thereof
03/25/1998CN1176760A Process for mfg. carotenoid compositions
1 ... 6675 6676 6677 6678 6679 6680 6681 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 ... 7860